This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
STI 571 strengthens its standing in CML. Inpharma Wkly. 1273, 7–8 (2001). https://doi.org/10.2165/00128413-200112730-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112730-00015